Taken together these results indicate that RAD51 depletion suppressed the metastatic spread of MDA-MB-231 cells and RAD51 overexpression enhanced the metastatic spread of BT549 cells, suggesting that RAD51 increases the metastatic potential of breast cancer in vivo. The gene discussed is RAD51; the disease is breast cancer.